Opioid Peptides Do Not Promote Nerve Growth in Spinal Cord Cultures — A Negative Result
Enkephalin, beta-endorphin, and dynorphin showed no growth-promoting or inhibiting effects on embryonic spinal cord neurons, indicating they are not growth factors for this tissue.
Quick Facts
What This Study Found
Enkephalin, beta-endorphin, and dynorphin are not growth factors for ventral spinal cord neurons. They did not affect neurite extension or glial cell proliferation in embryonic cultures.
Key Numbers
How They Did This
Ventral spinal cord explants from 13-14 day rat embryos were cultured with each opioid peptide. Neurite extension and glial cell numbers were measured and compared to controls.
Why This Research Matters
This negative result is informative. Despite opioid peptide genes being active early in development, the peptides themselves do not directly promote nerve growth in spinal cord tissue.
The Bigger Picture
Negative results are important in science. This study constrained the possible developmental roles of opioid peptides — they may guide brain development through signaling functions rather than direct growth promotion.
What This Study Doesn't Tell Us
Only ventral spinal cord was tested. Opioid peptides might affect growth in other brain regions. The culture conditions may not capture all relevant developmental signals. Concentrations tested were not detailed.
Questions This Raises
- ?Do opioid peptides promote growth in other brain regions?
- ?Could opioid peptides affect nerve development through indirect mechanisms not captured in culture?
Trust & Context
- Key Stat:
- No growth effect for any opioid peptide All three major opioid peptide types failed to affect neurite extension or glial proliferation in embryonic spinal cord
- Evidence Grade:
- Preliminary in-vitro study with a negative result. Limited by testing only one tissue type and potentially missing indirect growth effects.
- Study Age:
- Published in 1990. Subsequent research has shown opioid peptides may influence development through mechanisms other than direct growth promotion.
- Original Title:
- Trophic effects of enkephalin, beta-endorphine and dynorphine on ventral spinal cord in culture.
- Published In:
- The International journal of neuroscience, 50(3-4), 131-5 (1990)
- Authors:
- Iwasaki, Y, Kinoshita, M(5), Ikeda, K, Shiojima, T
- Database ID:
- RPEP-00159
Evidence Hierarchy
Frequently Asked Questions
Why is a negative result worth publishing?
Knowing what opioid peptides don't do is as important as knowing what they do. This ruled out a direct nerve growth factor role and redirected research toward other developmental mechanisms.
Could the peptides still affect brain development?
Yes. They might work through signaling, migration guidance, or circuit formation rather than direct growth promotion. They might also have effects in other brain regions that were not tested here.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00159APA
Iwasaki, Y; Kinoshita, M; Ikeda, K; Shiojima, T. (1990). Trophic effects of enkephalin, beta-endorphine and dynorphine on ventral spinal cord in culture.. The International journal of neuroscience, 50(3-4), 131-5.
MLA
Iwasaki, Y, et al. "Trophic effects of enkephalin, beta-endorphine and dynorphine on ventral spinal cord in culture.." The International journal of neuroscience, 1990.
RethinkPeptides
RethinkPeptides Research Database. "Trophic effects of enkephalin, beta-endorphine and dynorphin..." RPEP-00159. Retrieved from https://rethinkpeptides.com/research/iwasaki-1990-trophic-effects-of-enkephalin
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.